Afelimomab

Tax included
Afelimomab (MAK 195F) is an anti-tumor necrosis factor F(ab')2 monoclonal antibody fragment. Afelimomab can be used for the research of sepsis.
MedChemExpress 
HY-P99425

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor
Application
COVID-19-immunoregulation
CAS
156227-98-4